Name | Title | Contact Details |
---|---|---|
Nicoletta Loggia |
Chief Technical Officer | Profile |
Matt Manlove |
Vice President Information Technology | Profile |
Ran Zheng |
Chief Technical Officer | Profile |
Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. To accomplish this mission, we are building a synthetic biology platform that could enable us to program next-generation cell and gene therapies with what we refer to as “gene circuits”. These gene circuits, which are created from novel and proprietary combinations of DNA sequences, are intended to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We are designing gene circuits to improve the “intelligence” of cell and gene therapies in order to enhance their therapeutic effectiveness against a broad range of diseases that conventional medicines do not readily address.
Solutions for isolation, recovery, and analysis of intact, individual rare cells. Single "cell sorter"
Quadrant Laboratories is a subsidiary of Quadrant Biosciences, a life sciences company focused on improving the lives of children and families through innovative diagnostic, therapeutic, and virtual care solutions for global health priorities. Quadrant...
Stallergenes is a Norwell, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Transcept Pharmaceuticals, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.